儿童CKD风险预测工具跨人群验证
本研究在韩国儿童CKD队列中外部验证儿童CKD肾脏替代治疗风险预测计算器,纳入533例患儿,中位随访4.8年,171例(32.1%)启动KRT,模型区分度优秀(C统计量0.911-0.972),校准斜率均>0.9但拟合优度检验提示校准不良,纳入eGFR斜率的模型与观察风险最接近。
要点
- 该计算器在东亚儿童CKD队列中区分度优秀,C统计量0.911-0.972。
- 校准斜率均>0.9,但拟合优度检验提示校准不良(P<0.001)。
- 纳入eGFR斜率的模型预测风险与观察风险最接近。
核心结论
- 儿童CKD肾脏替代治疗风险预测计算器在东亚人群中具有潜在应用价值,可改善预后判断和临床决策。
研究设计与样本
- 基于韩国儿童CKD结局队列(KNOW-Ped CKD)的外部验证研究,纳入533例儿童,测试广义伽马家族六种参数生存模型,分为基于GFR变化组(组1,n=433)和横断面组(组2,n=533)。
主要发现
- 中位年龄10.8岁(IQR 5.3-14.5),基线eGFR中位57.6 ml/min per 1.73 m2(IQR 34.8-81.4)。
- 中位随访4.8年(IQR 2.0-8.9),171例(32.1%)启动KRT。
- 组1和组2模型区分度优秀,C统计量0.911-0.972。
- 所有模型校准斜率>0.9,但Greenwood-Nam-D'Agostino拟合优度检验提示校准不良(P<0.001)。
- 纳入eGFR斜率的模型与观察风险最接近。
临床怎么用
- 该计算器可用于儿童CKD患者的KRT风险预后评估,但需注意校准不良,尤其应关注纳入eGFR斜率的模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study aimed to externally validate the performance of the kidney replacement therapy (KRT) risk prediction calculator for chronic kidney disease (CKD) in children in an ethnically distinct East Asian population. METHODS: We externally validated the KRT risk prediction calculator for CKD in children using data from the KoreaN Cohort Study on Outcomes in Pediatric CKD (KNOW-Ped CKD) cohort. Six parametric survival models from the generalized gamma family were tested, stratified into 2 groups as follows: change in glomerular filtration rate (GFR)-based (group 1) and cross-sectional (group 2). Missing data (≤ 7.9%) were addressed via multiple imputations using chained equations. Outcomes were timed to KRT initiation. The model performance was evaluated based on goodness-of-fit, discrimination ability, calibration, and predictive ability. RESULTS: Overall, 533 children were included in the validation cohort. The median age and baseline estimated GFR (eGFR) were 10.8 years (interquartile range [IQR]: 5.3-14.5) and 57.6 ml/min per 1.73 m2 (IQR: 34.8-81.4), respectively. Over a median follow-up of 4.8 years (IQR: 2.0-8.9), KRT was initiated in 171 participants (32.1%). Models in group 1 (n = 433) and 2 (n = 533) demonstrated excellent discrimination ability (C-statistic: 0.911-0.972). The calibration slopes exceeded 0.9 across all models, though the Greenwood-Nam-D'Agostino goodness-of-fit test indicated a miscalibration (P < 0.001). Enriched models incorporating the eGFR slope showed the closest alignment with the observed risks. CONCLUSION: These findings underscore the potential utility of the calculator in improving prognostication and clinical decision-making in pediatric CKD.
引用
- Park PG, Kim J, Choi N, et al. Cross-Population Validation of the Pediatric CKD Risk-Prediction Tool. Kidney Int Rep. 2026. PMID: 41907822. doi:10.1016/j.ekir.2026.106373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。